Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV)

PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation (2019) Saleem H, Kulsoom Abdul U, Küçükosmanoglu A, Houweling M, Cornelissen FM, Heiland DH, Hegi ME, et al. Journal article The role of recessive inheritance in early-onset epileptic encephalopathies: a combined whole-exome sequencing and copy number study (2019) Papuc SM, Abela L, Steindl K, Begemann A, Simmons TL, Schmitt B, Zweier M, et al. Journal article Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors (2019) Dromain C, Pavel ME, Ruszniewski P, Langley A, Massien C, Baudin E, Caplin ME Journal article Diagnosis and Therapy before Assisted Reproductive TreatmentsGuideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019)-Part 1, Basic Assessment of the Woman (2019) Toth B, Baston-Buest DM, Behre HM, Bielfeld A, Bohlmann M, Buehling K, Dittrich R, et al. Journal article Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) – Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease (2019) Toth B, Baston-Buest DM, Behre H, Bielfeld A, Bohlmann M, Buehling K, Dittrich R, et al. Journal article Estimating the effect size of the 15Q11.2 BP1-BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice (2019) Jønch AE, Douard E, Moreau C, Van Dijck A, Passeggeri M, Kooy F, Puechberty J, et al. Journal article Problematic smartphone use in young Swiss men: Its association with problematic substance use and risk factors derived from the pathway model (2019) Dey M, Studer J, Schaub MP, Gmel G, Ebert D, Lee JYC, Haug S Journal article ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study (2019) Kolios AGA, Hueber A, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, Reinshagen M, et al. Journal article Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study (2019) Lamarca A, Crona J, Ronot M, Opalinska M, Lopez Lopez C, Pezzutti D, Najran P, et al. Journal article, Review article